home / stock / zldaf / zldaf quote
Last: | $0.48 |
---|---|
Change Percent: | 0.0% |
Open: | $0 |
Close: | $0.48 |
High: | $0 |
Low: | $0 |
Volume: | 5 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$0.48 | $0 | $0.48 | $0 | $0 | 5 | 05-03-2024 |
$0.48 | $0 | $0.48 | $0 | $0 | 5 | 04-16-2024 |
$0.48 | $0 | $0.48 | $0 | $0 | 22 | 04-11-2024 |
$0.48 | $0 | $0.48 | $0 | $0 | 81 | 04-09-2024 |
$0.48 | $0.4743 | $0.48 | $0.48 | $0.4743 | 2,005 | 04-04-2024 |
$0.4704 | $0.4704 | $0.4704 | $0.4704 | $0.4704 | 114 | 04-03-2024 |
$0.5308 | $0 | $0.5308 | $0 | $0 | 5 | 04-02-2024 |
$0.5308 | $0 | $0.5308 | $0 | $0 | 57 | 03-28-2024 |
$0.5308 | $0 | $0.5308 | $0 | $0 | 8 | 03-20-2024 |
$0.5308 | $0 | $0.5308 | $0 | $0 | 28 | 03-19-2024 |
$0.5308 | $0 | $0.5308 | $0 | $0 | 57 | 03-12-2024 |
$0.5308 | $0 | $0.5308 | $0 | $0 | 59 | 03-07-2024 |
$0.5308 | $0 | $0.5308 | $0 | $0 | 30 | 03-05-2024 |
$0.5308 | $0.5308 | $0.5308 | $0.5308 | $0.5308 | 1,449 | 03-04-2024 |
$0.60465 | $0 | $0.60465 | $0 | $0 | 1 | 02-27-2024 |
$0.60465 | $0 | $0.60465 | $0 | $0 | 28 | 02-23-2024 |
$0.60465 | $0 | $0.60465 | $0 | $0 | 5 | 02-09-2024 |
$0.60465 | $0 | $0.60465 | $0 | $0 | 9 | 02-08-2024 |
$0.60465 | $0 | $0.60465 | $0 | $0 | 85 | 02-06-2024 |
$0.60465 | $0 | $0.60465 | $0 | $0 | 8 | 02-05-2024 |
News, Short Squeeze, Breakout and More Instantly...
Zelda Therapeutics Ltd Company Name:
ZLDAF Stock Symbol:
OTCMKTS Market:
Zelira Therapeutics Ltd (ASX: ZLD) (OTCQB: ZLDAF) said that it has funding to conduct mid-to-late-stage FDA trials for its cannabinoid-based drug to treat autism spectrum disorder (ASD). The company received $8.6 million in funding from U.S.-based investment firm Cantheon Capital LLC to con...
Zelira Therapeutics Launches ZYRAYDI™ B2B Technology to Create Pharma-grade Cannabis Capsules & Tablets for Global Markets Zelira Therapeutics Launches ZYRAYDI™ B2B Technology to Create Pharma-grade Cannabis Capsules & Tablets for Global Markets PR News...
Zelira Therapeutics Ltd (ASX: ZLD,OTC-QB: ZLDAF ), recieved formal approval from German regulatory authority BfArM to launch in the German medical cannabis market for its new insomnia medication Zenivol. Zenivol is the first clinically validated , pharmaceutic...